GRCE — Grace Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Grace Therapeutics, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	43.7	27.9	23	22.1	17
Net Total Receivables	0.548	0.802	0.722	0.126	0.02
Prepaid Expenses
Total Other Current Assets
Total Current Assets	45.3	29.3	24	22.7	17.4
Net Property, Plant And Equipment	0.565	0.567	0.024	0.015	0.008
Net Goodwill
Net Intangible Assets
Total Assets	129	79.1	73.3	72	66.7
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	3.26	3.41	1.68	1.93	2.15
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	20.4	11.2	11.6	5.38	2.76
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	108	68	61.7	66.6	63.9
Total Liabilities & Shareholders' Equity	129	79.1	73.3	72	66.7
Total Common Shares Outstanding